PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1148283
PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1148283
The CAR-T Therapy market was valued at US$1.9 billion in 2021 and is projected to grow at a CAGR of 42.95% during the forecast period 2022-2032.
The CAR-T Therapy Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Factors Such As Increase in Funding From Venture Capitalist And Government Institutes And Increase In Global Burden of Cancer Benefits Are Driving the Market Growth
Some of the major forces propelling the CAR-T Therapy market include increase in funding from venture capitalist and government institutes and increase in global burden of cancer benefits. As per the data published by the WHO, cancer is a leading cause of death globally and caused almost 10 million deaths in 2020.
Based on current and projected population aging and growth, the American Cancer Society, Inc., predicts that the burden of cancer will increase to an estimated 29.4 million cases globally by 2040. China, with the largest population size worldwide has the highest global proportion of cancer new cases and deaths followed by Northern America in terms of new cases and fourth by cancer deaths. Increase in consumption of tobacco & alcohol, unhealthy diet, physical inactivity, and air pollution in various countries across the globe might further increase the cancer burden in future. In the past five years around US$12 billion have been invested by venture capital (VC) firms around the globe, an additional of US$2.2 billion of funding is raised through strategic partnerships between various institutes and biopharma companies.
Reimbursement Challenges and Side-effects of CAR-T Therapy
Reimbursement of CAR-T cell therapies has been a challenge to the healthcare providers, insurers and national & regional government agencies worldwide. CAR-T cell is amongst the most expensive drugs on the market with a price tag of around US$450,000 to US$500,000 per patient. Moreover, patient opting for CAR-T cell often have aggressive deceases resulting in rapid deterioration of health and thus any delays in payer approval can affect patient eligibility for CAR-T cell. Like every other cancer treatment, CAR-T cell therapy also poses severe side effects. Some of the most common occurring side effects are the cytokine release syndrome (CRS) and neurological effects.
What Questions Should You Ask before Buying a Market Research Report?
You need to discover how this will impact the CAR-T Therapy market today, and over the next 10 years:
This report tells you TODAY how the CAR-T Therapy market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2032 and other analyses reveal commercial prospects
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report
Indication
Type
Target Antigens
Patient
End User
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 10 leading national markets:
North America
Europe
Asia Pacific
Latin America
MEA
The report also includes profiles and for some of the leading companies in the CAR-T Therapy Market, 2022 to 2032, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth
Overall world revenue for CAR-T Therapy Market, 2022 to 2032 in terms of value the market will surpass US$2.8 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the CAR-T Therapy Market, 2022 to 2032 report help you?
In summary, our 250+ page report provides you with the following knowledge:
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the CAR-T Therapy Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.